Proprotein convertase subtilisin kexin type 9 (PCSK9) [PDF]
Science-Business eXchange, 2009 openaire +1 more source
Letter to the editor regarding "Long-term mortality in pediatric sepsis: a systematic review and meta-analysis". [PDF]
Ann MedJi K, Duan X.
europepmc +1 more source
Correction: Dai et al. Mallotucin D, a Clerodane Diterpenoid from <i>Croton crassifolius</i>, Suppresses HepG2 Cell Growth via Inducing Autophagic Cell Death and Pyroptosis. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 14217. [PDF]
Int J Mol SciDai X +9 more
europepmc +1 more source
Proprotein convertase subtilisin/kexin type 9 (PCSK9) [PDF]
Science-Business eXchange, 2012 openaire +1 more source
New-onset vitiligo following proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab: A possible immune-mediated adverse effect. [PDF]
JAAD Case RepUmaña Mejia CA +3 more
europepmc +1 more source
Proprotein convertase subtilisin/kexin type 9 expression is transiently up-regulated in the acute period of myocardial infarction in rat [PDF]
, 2014 core +1 more source
Tongue-coating microbiome as a predictor of solid tumors: an updated scoping review of clinical studies. [PDF]
J Tradit Chin MedKexin LI +4 more
europepmc +1 more source
LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice [PDF]
, 2018 Jeong, Lak Shin +5 more
core +1 more source
Comment on: "Association of Fasting C-Peptide to High Density Lipoprotein Cholesterol Ratio with Non-Alcoholic Fatty Liver Disease in Chinese Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study" [Letter]. [PDF]
Diabetes Metab Syndr ObesHu K, Xu H.
europepmc +1 more source